Abliva AB (publ) informed that Dr. Edwin Moses (Director) is no longer available for re-election for personal reasons.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1968 SEK | +2.61% | +8.37% | -19.84% |
Feb. 23 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
2023 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.84% | 22.04M | |
+4.78% | 111B | |
+12.23% | 105B | |
-12.71% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.73% | 16.96B | |
+4.42% | 13.7B | |
+36.74% | 12.45B |
- Stock Market
- Equities
- ABLI Stock
- News Abliva AB
- Abliva AB Announces Resignation of Edwin Moses as Director